Suppr超能文献

[细菌性肺炎住院患者的预后及危险因素]

[Prognostic and risk factors in patients hospitalized with bacterial pneumonia].

作者信息

Kondo Akira, Morinaga Yoshitomo, Sasaki Eisuke, Hisamatsu Takashi, Izumikawa Kinichi, Hara Kohei, Izumikawa Koichi, Kohno Shigeru

出版信息

Kansenshogaku Zasshi. 2007 May;81(3):268-75. doi: 10.11150/kansenshogakuzasshi1970.81.268.

Abstract

We studied 316 adults with community-and hospital-acquired bacterial pneumonia admitted from January 1998 to July 2003. Of these, 66 (20.9%) died. Classified by age, none under 70 died, but mortality increased to 22.6% in the 70-79 age group, 31.6% in the 80-89 age group and 24.2% in the group over 90. Mortality was 3.4% (6/177) for mild pneumonia, 32.0% (24/75) for moderate pneumonia, and 56.3% (36/64) for severe pneumonia. Mortality in hospital-acquired pneumonia (69.1%) was significantly higher than that in community-acquired pneumonia (10.7%). This may result from the higher percentage of moderate by and severe by ill patients who contracted hospital-acquired pneumonia, since 80% of those with hospital-acquired pneumonia were in the moderate and severe group compared to 36.4% of those with community-acquired pneumonia. For antibiotic regimens, mortality was 18.2% to 36.4% for patients who underwent Penicillins-Cephems therapy compared with 51.6% to 66.7% for Carbapenems-Quinolones therapy. The reasons for these differences remain unclear. Our study indicates that severity of illness, age, and antibiotic therapy were factors correlated with death from pneumonia. Underlying diseases such as respiratory failure, chronic heart failure, cerebrovascular disease, renal failure, malignancy, and senile dementia may also be associated with mortality.

摘要

我们研究了1998年1月至2003年7月期间收治的316例社区获得性和医院获得性细菌性肺炎成人患者。其中,66例(20.9%)死亡。按年龄分类,70岁以下患者无死亡病例,但70 - 79岁年龄组死亡率增至22.6%,80 - 89岁年龄组为31.6%,90岁以上年龄组为24.2%。轻度肺炎死亡率为3.4%(6/177),中度肺炎为32.0%(24/75),重度肺炎为56.3%(36/64)。医院获得性肺炎的死亡率(69.1%)显著高于社区获得性肺炎(10.7%)。这可能是由于患医院获得性肺炎的中度和重度患者比例较高,因为80%的医院获得性肺炎患者属于中度和重度组,而社区获得性肺炎患者这一比例为36.4%。对于抗生素治疗方案,接受青霉素 - 头孢菌素治疗的患者死亡率为18.2%至36.4%,而接受碳青霉烯类 - 喹诺酮类治疗的患者死亡率为51.6%至66.7%。这些差异的原因尚不清楚。我们的研究表明,疾病严重程度、年龄和抗生素治疗是与肺炎死亡相关的因素。呼吸衰竭、慢性心力衰竭、脑血管疾病、肾衰竭、恶性肿瘤和老年痴呆等基础疾病也可能与死亡率相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验